These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38571440)

  • 1. Genetic testing in cardiovascular disease.
    Gray MP; Fatkin D; Ingles J; Robertson EN; Figtree GA
    Med J Aust; 2024 May; 220(8):428-434. PubMed ID: 38571440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    O'Sullivan JW; Raghavan S; Marquez-Luna C; Luzum JA; Damrauer SM; Ashley EA; O'Donnell CJ; Willer CJ; Natarajan P;
    Circulation; 2022 Aug; 146(8):e93-e118. PubMed ID: 35862132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases.
    Abraham G; Rutten-Jacobs L; Inouye M
    Stroke; 2021 Aug; 52(9):2983-2991. PubMed ID: 34399584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of direct-to-consumer genetic testing for cardiovascular disease risk.
    Austin SE; Hegele RA
    Can J Cardiol; 2011; 27(6):682-4. PubMed ID: 21652171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic testing in polygenic diseases : Atrial fibrillation, arterial hypertension and coronary artery disease].
    Trenkwalder T; Kessler T; Schunkert H
    Herz; 2017 Aug; 42(5):440-448. PubMed ID: 28536780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2010 Dec; 12(12):839-43. PubMed ID: 21042222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
    Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
    J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polygenic risk prediction of common diseases: from epidemiology to clinical application].
    Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
    Vrablik M; Dlouha D; Todorovova V; Stefler D; Hubacek JA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a novel rapid genomic test including polygenic risk scores for the diagnosis and management of familial hypercholesterolaemia.
    Neves E; Khan T; Williams M; Carrera M; Banya W; Brugada R; Ferrer C; Morris-Rosendahl DJ; Barbir M
    Glob Cardiol Sci Pract; 2021 Dec; 2021(4):e202131. PubMed ID: 36185161
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic Testing in Cardiovascular Medicine.
    Marian AJ
    Tex Heart Inst J; 2018 Aug; 45(4):231-232. PubMed ID: 30374232
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.
    Trinder M; Francis GA; Brunham LR
    JAMA Cardiol; 2020 Apr; 5(4):390-399. PubMed ID: 32049305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expansion of Genetic Testing in Cardiovascular Medicine: Preparing the Cardiology Community for the Changing Landscape.
    Reza N; Alford RL; Belmont JW; Marston N
    Curr Cardiol Rep; 2024 Mar; 26(3):135-146. PubMed ID: 38277082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association.
    Musunuru K; Hershberger RE; Day SM; Klinedinst NJ; Landstrom AP; Parikh VN; Prakash S; Semsarian C; Sturm AC;
    Circ Genom Precis Med; 2020 Aug; 13(4):e000067. PubMed ID: 32698598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using genetics to detangle the relationships between red cell distribution width and cardiovascular diseases: a unique role for body mass index.
    Thayer TE; Huang S; Farber-Eger E; Beckman JA; Brittain EL; Mosley JD; Wells QS
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34521746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing applications for cardiovascular disease.
    Kalayinia S; Goodarzynejad H; Maleki M; Mahdieh N
    Ann Med; 2018 Mar; 50(2):91-109. PubMed ID: 29027470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease.
    Naito T; Botwin GJ; Haritunians T; Li D; Yang S; Khrom M; Braun J; ; Abbou L; Mengesha E; Stevens C; Masamune A; Daly M; McGovern DPB
    Gastroenterology; 2021 Feb; 160(3):771-780.e4. PubMed ID: 33098885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of genetic markers for improved risk estimation.
    Kessler T; Schunkert H
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):25-32. PubMed ID: 22801067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.